\babel@toc {english}{}\relax 
\contentsline {chapter}{\numberline {1}Introduction}{3}{chapter.1}%
\contentsline {subsection}{\numberline {1.0.1}Genetic Make-Up}{4}{subsection.1.0.1}%
\contentsline {subsubsection}{\numberline {1.0.1.1}Differences in genetic Make-Up, example}{5}{subsubsection.1.0.1.1}%
\contentsline {subsection}{\numberline {1.0.2}Acquired DNA aberrations}{6}{subsection.1.0.2}%
\contentsline {section}{\numberline {1.1}Experimental approaches}{8}{section.1.1}%
\contentsline {subsubsection}{\numberline {1.1.0.1}Single End (SE) sequencing}{10}{subsubsection.1.1.0.1}%
\contentsline {subsubsection}{\numberline {1.1.0.2}Paired End (PE) sequencing}{11}{subsubsection.1.1.0.2}%
\contentsline {subsubsection}{\numberline {1.1.0.3}Difference between sequence coverage and physical coverage}{13}{subsubsection.1.1.0.3}%
\contentsline {subsubsection}{\numberline {1.1.0.4}1st panel - LNCaP sample (cell line)}{15}{subsubsection.1.1.0.4}%
\contentsline {subsubsection}{\numberline {1.1.0.5}2nd panel - PC3 sample (cell line)}{15}{subsubsection.1.1.0.5}%
\contentsline {subsubsection}{\numberline {1.1.0.6}3rd panel - VCaP sample (cell line)}{16}{subsubsection.1.1.0.6}%
\contentsline {subsubsection}{\numberline {1.1.0.7}Note that this isn't possible with array-based technologies.}{16}{subsubsection.1.1.0.7}%
\contentsline {section}{\numberline {1.2}The reference sequence of the human genome}{16}{section.1.2}%
\contentsline {subsection}{\numberline {1.2.1}Interpreting pair orientation}{17}{subsection.1.2.1}%
\contentsline {subsection}{\numberline {1.2.2}Inversion}{18}{subsection.1.2.2}%
\contentsline {subsection}{\numberline {1.2.3}Tandem duplication}{20}{subsection.1.2.3}%
\contentsline {subsection}{\numberline {1.2.4}Inverted duplication}{21}{subsection.1.2.4}%
\contentsline {subsection}{\numberline {1.2.5}Deletion}{23}{subsection.1.2.5}%
\contentsline {chapter}{\numberline {2}Genetic Figerprinting}{24}{chapter.2}%
\contentsline {subsection}{\numberline {2.0.1}Variants used for genetic testing}{24}{subsection.2.0.1}%
\contentsline {section}{\numberline {2.1}SNPs features}{24}{section.2.1}%
\contentsline {subsection}{\numberline {2.1.1}Hardy-Weinberg equilibrium and Minor Allele frequency}{24}{subsection.2.1.1}%
\contentsline {subsection}{\numberline {2.1.2}Minor Allele Frequency}{25}{subsection.2.1.2}%
\contentsline {subsection}{\numberline {2.1.3}Haplotype Blocks}{25}{subsection.2.1.3}%
\contentsline {subsection}{\numberline {2.1.4}Other SNPs features}{26}{subsection.2.1.4}%
\contentsline {subsection}{\numberline {2.1.5}Number of SNPs to select}{27}{subsection.2.1.5}%
\contentsline {subsubsection}{\numberline {2.1.5.1}Experimental mismatches : Genotype call error rate}{27}{subsubsection.2.1.5.1}%
\contentsline {paragraph}{\numberline {2.1.5.1.1}Some examples:}{27}{figure.caption.3}%
\contentsline {subsubsection}{\numberline {2.1.5.2}Biological mismatches}{28}{subsubsection.2.1.5.2}%
\contentsline {section}{\numberline {2.2}Genetic Distance}{28}{section.2.2}%
\contentsline {subsection}{\numberline {2.2.1}Some questions}{31}{subsection.2.2.1}%
\contentsline {subsection}{\numberline {2.2.2}Further considerations}{31}{subsection.2.2.2}%
\contentsline {section}{\numberline {2.3}Building a SNP-based genetic test}{32}{section.2.3}%
\contentsline {subsection}{\numberline {2.3.1}Implementation of a probabilistic test}{33}{subsection.2.3.1}%
\contentsline {section}{\numberline {2.4}Further considerations and examples}{34}{section.2.4}%
\contentsline {subsection}{\numberline {2.4.1}Example 1: Cell line passages}{34}{subsection.2.4.1}%
\contentsline {subsection}{\numberline {2.4.2}Individual's Relatedness (genotype-distance)}{35}{subsection.2.4.2}%
\contentsline {subsection}{\numberline {2.4.3}Example 3: Cancer supscettibility test}{36}{subsection.2.4.3}%
\contentsline {subsection}{\numberline {2.4.4}Genetic structure of the human population}{36}{subsection.2.4.4}%
\contentsline {subsubsection}{\numberline {2.4.4.1}Example paper: 'Genes mirror geography within Europe'}{37}{subsubsection.2.4.4.1}%
\contentsline {subsubsection}{\numberline {2.4.4.2}Summary and notes}{38}{subsubsection.2.4.4.2}%
\contentsline {subsection}{\numberline {2.4.5}SPIA Assay}{38}{subsection.2.4.5}%
\contentsline {chapter}{\numberline {3}IGV (Integrative Genomics Viewer)}{40}{chapter.3}%
\contentsline {section}{\numberline {3.1}Main characteristics}{40}{section.3.1}%
\contentsline {subsection}{\numberline {3.1.1}Igvtools}{42}{subsection.3.1.1}%
\contentsline {subsection}{\numberline {3.1.2}Session Files}{43}{subsection.3.1.2}%
\contentsline {section}{\numberline {3.2}Some of the main utilizations}{43}{section.3.2}%
\contentsline {subsection}{\numberline {3.2.1}RNA-seq alignments}{44}{subsection.3.2.1}%
\contentsline {subsection}{\numberline {3.2.2}Study of variants}{44}{subsection.3.2.2}%
\contentsline {section}{\numberline {3.3}Exercise}{44}{section.3.3}%
\contentsline {chapter}{\numberline {4}Tumor evolution studies (continued)}{47}{chapter.4}%
\contentsline {section}{\numberline {4.1}Recalls from the previous lecture}{47}{section.4.1}%
\contentsline {section}{\numberline {4.2}Ploidy and purity correction on $\qopname \relax o{log}_2(\frac {T}{N})$ data}{52}{section.4.2}%
